Cargando…

Determining Ribavirin’s mechanism of action against Lassa virus infection

Ribavirin is a broad spectrum antiviral which inhibits Lassa virus (LASV) replication in vitro but exhibits a minor effect on viremia in vivo. However, ribavirin significantly improves the disease outcome when administered in combination with sub-optimal doses of favipiravir, a strong antiviral drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrillo-Bustamante, Paola, Nguyen, Thi Huyen Tram, Oestereich, Lisa, Günther, Stephan, Guedj, Jeremie, Graw, Frederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601963/ https://www.ncbi.nlm.nih.gov/pubmed/28916737 http://dx.doi.org/10.1038/s41598-017-10198-0

Ejemplares similares

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
por: Lingas, Guillaume, et al.
Publicado: (2021)

Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials
por: Madelain, Vincent, et al.
Publicado: (2020)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
por: Okogbenin, Sylvanus, et al.
Publicado: (2022)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria
por: Erameh, Cyril, et al.
Publicado: (2020)

Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021)

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
por: Groger, Mirjam, et al.
Publicado: (2022)

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques
por: Guedj, Jérémie, et al.
Publicado: (2018)

Detection of Lassa Virus-Reactive IgG Antibodies in Wild Rodents: Validation of a Capture Enzyme-Linked Immunological Assay
por: Soubrier, Hugo, et al.
Publicado: (2022)

The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?
por: Nguyen, Thi Huyen Tram, et al.
Publicado: (2017)

Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
por: Cheng, Hung-Yuan, et al.
Publicado: (2022)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
por: Yadouleton, Anges, et al.
Publicado: (2020)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
por: Oestereich, Lisa, et al.
Publicado: (2014)

Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
por: Oestereich, Lisa, et al.
Publicado: (2023)

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
por: Salam, Alex P., et al.
Publicado: (2022)

Phylogeography of Lassa Virus in Nigeria
por: Ehichioya, Deborah U., et al.
Publicado: (2019)

Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea
por: Mariën, Joachim, et al.
Publicado: (2020)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Biochemical characterization of the Lassa virus L protein
por: Vogel, Dominik, et al.
Publicado: (2019)

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
por: Boisen, Matthew L., et al.
Publicado: (2020)

New Hosts of The Lassa Virus
por: Olayemi, Ayodeji, et al.
Publicado: (2016)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues
por: Port, Julia R., et al.
Publicado: (2020)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)

International External Quality Assessment Study for Molecular Detection of Lassa Virus
por: Nikisins, Sergejs, et al.
Publicado: (2015)

Kinetic Determination of Ribavirin in Drug Formulations
por: El-Brashy, A. M., et al.
Publicado: (2007)

Mastomys natalensis and Lassa Fever, West Africa
por: Lecompte, Emilie, et al.
Publicado: (2006)

Screening of Botanical Drugs against Lassa Virus Entry
por: Liu, Yang, et al.
Publicado: (2021)

Neutralizing Antibodies against Lassa Virus Lineage I
por: Buck, Tierra K., et al.
Publicado: (2022)

Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro
por: Günther, Stephan, et al.
Publicado: (2004)

Lassa Virus in Pygmy Mice, Benin, 2016–2017
por: Yadouleton, Anges, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q0acma05peb84hija4q5p87202